Salvia miltiorrhiza extract improves menopausal symptoms in naturally aged mice

Abstract

Objective: To investigate the efficacy and underlying mechanisms of standardized Salvia miltiorrhiza extract (SMEX) in alleviating menopausal symptoms using MCF-7 cells and an ovary-intact menopause mouse model resulting from hypothalamic-pituitary-ovarian axis aging.

Methods: Estrogen receptor (ER)-related molecular responses were first assessed in MCF-7 cells treated with SMEX. In vivo efficacy was then evaluated in 52-week-old female mice orally administered SMEX (50 or 100 mg/kg/day) or 17β-estradiol (E2) for 12 weeks. ER expression and downstream AKT/ERK signaling pathways in uterine tissues were determined. In addition, histological analysis of reproductive organs, assessment of serum lipid and hormone levels, neurotransmitter measurements, and behavioral tests were performed.

Results: SMEX upregulated ERα and ERβ expression and suppressed pS2 mRNA in MCF-7 cells, indicating selective ER modulation. In SMEX-treated mice, uterine ER expression and activation of the AKT and ERK pathways were significantly increased, leading to partial restoration of epithelial thickness and stratification in the oviduct and vagina. SMEX also significantly reduced serum low-density lipoprotein cholesterol levels and reversed menopausal alterations in the follicle-stimulating hormone/ luteinizing hormone ratio. Additionally, it elevated serotonin and norepinephrine levels in the pituitary, thereby alleviating depressionlike behavior.

Conclusions: SMEX modulates ER signaling and improves neurohormonal balance, effectively alleviating menopausal symptoms in both in vitro and in vivo models. This highlights its potential as a safe, natural alternative to hormone replacement therapy and as a promising functional ingredient in therapeutic natural products.

Keywords

Salvia miltiorrhiza extract / Selective ER modulation / Ovary-intact menopause model

Conflict of interest statement

The authors declare there is no conflict of interest.

Funding

This study was funded by UNDBIO Co., Ltd. No specific grant number was assigned.

Data availability statement

The data supporting the findings of this study are available from the corresponding authors upon request.

Authors’ contributions

SCK and HK contributed to the conception and design of the study. HK and JP contributed to funding acquisition. GK and JEK carried out investigations. JEK, YGL, and GK were involved in data curation. JEK, YGL, YMC, and SCK were responsible for statistical analysis and interpretation of the data. YMC and SCK contributed to validation. GK, JEK, and YGL contributed to visualization. SCK contributed to project administration and supervision. JEK, YMC, and GK drafted the original manuscript. JEK, YGL, YMC, and SCK made critical revision of the manuscript. All authors approved the final version of the manuscript.

Publisher’s note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Acknowledgments

We would like to express our gratitude to Dr. Inhye Kim of Medi&Friends Co., Ltd. for supporting researchers in publishing their papers. UNDBIO Co., Ltd provided UND-MENO Q® and study funding.

References

[1] Fang ZY, Lin R, Yuan BX, Yang GD, Liu Y, Zhang H. Tanshinone IIA downregulates the CD 40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit. J Ethnopharmacol 2008; 115(2): 217-222.

[2] Wang J, Ke W, Bao R, Hu X, Chen F. Beneficial effects of ginger Zingiber officinale Roscoe on obesity and metabolic syndrome: A review. Ann N Y Acad Sci 2017; 1398(1): 83-98.

[3] Peng Y, Yang T, Huang K, Shen L, Tao Y, Liu C. Salvia miltiorrhiza ameliorates liver fibrosis by activating hepatic natural killer cells in vivo and in vitro. Front Pharmacol 2018; 9: 762.

[4] Wei B, Sun C, Wan H, Shou Q, Han B, Sheng M, et al. Bioactive components and molecular mechanisms of Salvia miltiorrhiza Bunge in promoting blood circulation to remove blood stasis. J Ethnopharmacol 2023; 317: 116697.

[5] Xu Y, Chen T, Li X, Qu Y, An J, Zheng H, et al. Salvia miltiorrhiza Bunge increases estrogen level without side effects on reproductive tissues in immature/ovariectomized mice. Aging 2016; 9(1): 156-172.

[6] Park B, Song HS, Kwon JE, Cho SM, Jang SA, Kim MY, et al. Effects of Salvia miltiorrhiza extract with supplemental liquefied calcium on osteoporosis in calcium-deficient ovariectomized mice. BMC Complement Altern Med 2017; 17(1): 545.

[7] Lee SR, Jeon H, Kwon JE, Suh H, Kim BH, Yun MK, et al. Antiosteoporotic effects of Salvia miltiorrhiza Bunge EtOH extract both in ovariectomized and naturally menopausal mouse models. J Ethnopharmacol 2020; 258: 112874.

[8] Kwon JE, Lee YG, Kim TH, Gang G, Altun G, Ahmed FM, et al. Treatment of postmenopausal syndrome with UBPN01: A randomized, double-blind, placebo-controlled study. J Food Nutr Res 2022; 10(7): 496-502.

[9] O’Neill S, Eden J. The pathophysiology of menopausal symptoms. Obstet Gynaecol Reprod Med 2012; 22(3): 63-69.

[10] Santoro N, Roeca C, Peters BA, Neal-Perry G. The menopause transition: Signs, symptoms, and management options. J Clin Endocrinol Metab 2021; 106(1): 1-15.

[11] Talaulikar V. Menopause transition: Physiology and symptoms. Best Pract Res Clin Obstet Gynaecol 2022; 81: 3-7.

[12] Fang Y, Liu F, Zhang X, Chen L, Liu Y, Yang L, et al. Mapping global prevalence of menopausal symptoms among middle-aged women: A systematic review and meta-analysis. BMC Public Health 2024; 24(1): 1767.

[13] Taylor A, Clement K, Hillard T, Sassarini J, Ratnavelu N, Baker-Rand H, et al. British gynaecological cancer society and British menopause society guidelines: Management of menopausal symptoms following treatment of gynaecological cancer. Post Reprod Health 2024; 30(4): 256-279.

[14] Cameron CR, Cohen S, Swell K, Lee M. The art of hormone replacement therapy (HRT) in menopause management. J Pharm Pract 2024; 37(3): 736-740.

[15] Bean LA, Ianov L, Foster TC. Estrogen receptors, the hippocampus, and memory. Neuroscientist 2014; 20(5): 534-545.

[16] Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982; 10(24): 7895-7903.

[17] Sreeja S, Anju VS, Sreeja S. In vitro estrogenic activities of fenugreek Trigonella foenum graecum seeds. Indian J Med Res 2010; 131: 814-819.

[18] Koebele SV, Bimonte-Nelson HA. Modeling menopause: The utility of rodents in translational behavioral endocrinology research. Maturitas 2016; 87: 5-17.

[19] Devillers MM, Mhaouty-Kodija S, Guigon CJ. Deciphering the roles and regulation of estradiol signaling during female mini-puberty: Insights from mouse models. Int J Mol Sci 2022; 23(22): 13695.

[20] Ahmadian S, Sheshpari S, Mahdipour M, Pazhang M, Tsai PJ, Nouri M, et al. Toxic effects of VCD on kidneys and liver tissues: A histopathological and biochemical study. BMC Res Notes 2019; 12(1): 446.

[21] Tanaka T, Tang H, Umehara K, Moriyama T, Kawamura Y. Kudzu (Pueraria lobata) vine isoflavones, at a dose lower than the recommended daily allowance in Japan, prevents bone loss in ovariectomized mice. Food Sci Technol Res 2023; 29(1): 47-55.

[22] Tanaka T, Hironaka R, Fukuda T, Ando M, Shirasaka N, Homma Y. Dietary vanillic acid prevents postmenopausal symptoms in ovariectomized mice. Food Sci Technol Res 2024; 30(1): 97-106.

[23] Chen P, Li B, Ou-Yang L. Role of estrogen receptors in health and disease. Front Endocrinol 2022; 13.

[24] Kim D, Liu QF, Jeong HJ, Han SH, Kim DI, Jeon S. A modified formulation of Sutaehwan ameliorates menopausal anxiety, depression and heart hypertrophy in the VCD-induced menopausal mouse model. Biol Pharm Bull 2019; 42(9): 1471-1481.

[25] Ochiel DO, Fahey JV, Ghosh M, Haddad SN, Wira CR. Innate immunity in the female reproductive tract: Role of sex hormones in regulating uterine epithelial cell protection against pathogens. Curr Womens Health Rev 2008; 4(2): 102-117.

[26] Park DR, Yeo CH, Yoon JE, Hong EY, Choi BR, Lee YJ, et al. Polygonatum sibiricum improves menopause symptoms by regulating hormone receptor balance in an ovariectomized mouse model. Biomed Pharmacother 2022; 153. doi: 10.1016/j.biopha.2022.113385.

[27] Ko SH, Kim HS. Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women. Nutrients 2020; 12(1). doi: 10.3390/nu12010202.

[28] Thaung Zaw JJ, Howe PRC, Wong RHX. Postmenopausal health interventions: Time to move on from the women’s health initiative? Aging Res Rev 2018; 48: 79-86.

[29] Kumari R, Ponte ME, Franczak E, Prom JC, O’Neil MF, Sardiu ME, et al. VCD-induced menopause mouse model reveals reprogramming of hepatic metabolism. Mol Metab 2024; 82. doi: 10.1016/j.molmet.2024.101908.

[30] Messinis IE. From menarche to regular menstruation. Ann N Y Acad Sci 2007; 1092(1): 49-56.

[31] Al-Azzawi F, Palacios S. Hormonal changes during menopause. Maturitas 2009; 63(2): 135-137.

[32] Turek J, Gąsior Ł. Estrogen fluctuations during the menopausal transition are a risk factor for depressive disorders. Pharmacol Rep 2023; 75(1): 3243.

[33] McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999; 20(3): 279-307.

[34] Hernández-Hernández OT, Martínez-Mota L, Herrera-Pérez JJ, Jiménez-Rubio G. Role of estradiol in the expression of genes involved in serotonin neurotransmission: Implications for female depression. Curr Neuropharmacol 2019; 17(5): 459-471.

[35] Liang G, Kow ASF, Yusof R, Tham CL, Ho YC, Lee MT. Menopause-associated depression: Impact of oxidative stress and neuroinflammation on the central nervous system—a review. Biomedicines 2024; 12(1). doi: 10.3390/biomedicines12010184.

[36] Zhnardi R, Rossini D, Magri L, Malaguti A, Colombo C, Smeraldi E. Response to SSRIs and role of the hormonal therapy in post-menopausal depression. Eur Neuropsychopharmacol 2007; 17(6-7): 400-405.

[37] Young EA, Altemus M, Parkison V, Shastry S. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacol 2001; 25(6): 881-891.

[38] Lim HJ, Cho CH, Lee SH, Won YS, Bak SG, Kim M, et al. Estrogenic active Ecklonia cava extract improves bone loss and depressive behaviour in OVX mice. J Funct Foods 2023; 101. doi: 10.1016/j.jff.2023.105423.

[39] Zhou XD, Shi DD, Wang HN, Tan QR, Zhang ZJ. Aqueous extract of lily bulb ameliorates menopause-like behavior in ovariectomized mice with novel brain-uterus mechanisms distinct from estrogen therapy. Biomed Pharmacother 2019; 117. doi: 10.1016/j.biopha.2019.109114.

[40] Kim HR, Lee YJ, Kim TW, Lim RN, Hwang DY, Moffat JJ, et al. Asparagus cochinchinensis extract ameliorates menopausal depression in ovariectomized rats under chronic unpredictable mild stress. BMC Complement Med Ther 2020; 20(1). doi: 10.1186/s12906-020-03121-0.

[41] Lemini C, García-Albor E, Cruz-López, Matamoros-Trejo G, Márquez-Baltazar S, Herrera-Pérez JJ, et al. Prolame produces anxiolytic- and antidepressant-like effects in middle-aged female rats with less uterotrophic effects than 17β-estradiol. Eur J Pharmacol 2024; 969. doi: 10.1016/j.ejphar.2024.176454.